GRCL Overview
Upcoming Projects (GRCL)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (GRCL)
-
A Third Look: Discussing the potential of CAR-T applications in immunology and autoimmune diseases.
Tickers: AZN, KYTX, CABA, NKTX, GRCL, Artiva Biotherapeutics
Executed On: May 30, 2024 at 04:30 PM EDT -
A Second Look: Discussing the potential of CAR-T applications in immunology and autoimmune diseases.
Tickers: AZN, KYTX, CABA, NKTX, GRCL, Artiva Biotherapeutics
Executed On: May 24, 2024 at 09:00 AM EDT -
Discussing the potential of CAR-T applications in immunology and autoimmune diseases.
Tickers: KYTX, CABA, NKTX, GRCL, AZN, Artiva Biotherapeutics
Executed On: May 23, 2024 at 11:00 AM EDT -
Discussing the potential of Gracell Biotechnologies CD19 and BCMA dual-targeting CAR-T cell therapy, GC012F, in B-Cell Non-Hodgkin’s Lymphoma and the Phase 1 data presented at EHA2023.
Ticker: GRCL
Executed On: Aug 01, 2023 at 08:00 AM EDT -
Discussing the current treatment landscape and the potential Gracell Biotechnologies' GC007g in B-cell acute lymphoblastic leukemia.
Ticker: GRCL
Executed On: May 23, 2023 at 06:00 PM EDT -
A look at the potential of new CAR-T cell therapies in development for multiple myeloma
Tickers: ACLX, GRCL, OriCell Therapeutics, JNJ, LEGN, TSVT
Executed On: Jul 14, 2022 at 08:00 AM EDT
Upcoming & Overdue Catalysts (GRCL)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (GRCL)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
